Cargando…
Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P124 |
| _version_ | 1782351970768519168 |
|---|---|
| author | Foy, Susan P Rountree, Ryan B Cote, Joseph dela Cruz, Tracy Gordon, Evan Trent, Erica Franzusoff, Alex Breitmeyer, James B Mandl, Stefanie J |
| author_facet | Foy, Susan P Rountree, Ryan B Cote, Joseph dela Cruz, Tracy Gordon, Evan Trent, Erica Franzusoff, Alex Breitmeyer, James B Mandl, Stefanie J |
| author_sort | Foy, Susan P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288427 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42884272015-01-15 Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer Foy, Susan P Rountree, Ryan B Cote, Joseph dela Cruz, Tracy Gordon, Evan Trent, Erica Franzusoff, Alex Breitmeyer, James B Mandl, Stefanie J J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P124 Text en Copyright © 2014 Foy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Foy, Susan P Rountree, Ryan B Cote, Joseph dela Cruz, Tracy Gordon, Evan Trent, Erica Franzusoff, Alex Breitmeyer, James B Mandl, Stefanie J Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title | Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title_full | Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title_fullStr | Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title_full_unstemmed | Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title_short | Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| title_sort | poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288427/ http://dx.doi.org/10.1186/2051-1426-2-S3-P124 |
| work_keys_str_mv | AT foysusanp poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT rountreeryanb poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT cotejoseph poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT delacruztracy poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT gordonevan poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT trenterica poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT franzusoffalex poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT breitmeyerjamesb poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer AT mandlstefaniej poxvirusbasedactiveimmunotherapysynergizeswithimmunecheckpointinhibitorstocausetumorregressionandextendsurvivalinpreclinicalmodelsofcancer |